Related Experiment Videos
Sn-glycerol-3-phosphate dehydrogenase gene expression during mouse adipocyte development in vivo
Developmental Biology
|August 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Validation of a molecular diagnostic assay for CALR exon 9 indels in myeloproliferative neoplasms: identification of coexisting JAK2 and CALR mutations and a novel 9 bp deletion in CALR.
International journal of laboratory hematology·2016
Multiple repeat caesarean section in the UK: incidence and consequences to mother and child. A national, prospective, cohort study.
BJOG : an international journal of obstetrics and gynaecology·2012
Effects of applied electric fields on clinical cases of complete paraplegia in dogs.
Restorative neurology and neuroscience·2011
Shedding light on the proteolytically released ectodomains of membrane-bound Semaphorins.
Developmental biology·2026
Notch-regulated hematopoiesis in Drosophila: Parallels and contrasts with vertebrate blood development.
Developmental biology·2026
Orbital Septal Fascial Flap with Extensive Release of a Long Orbital Fat Flap for Correcting Lower Eyelid Bags Associated with Midface Depression.
Journal of visualized experiments : JoVE·2026
Adipose-derived microRNA-518a drives hepatic cholesterol dysregulation and hypertension-related vascular remodeling in metabolic dysfunction-associated steatohepatitis via the MST1-AMPK-SREBP2 axis.
Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Extracellular Vesicle Surface Protein Profiling in Metabolic Dysfunction-associated Steatotic Liver Disease in Obesity.
Journal of extracellular biology·2026
Prevalence and Associated Factors of Metabolic Dysfunction-Associated Steatotic Liver Disease Across Obesity Metabolic Phenotypes in Chronic Schizophrenia.
International journal of general medicine·2026
The association between BMI and cognition, disability, and quality of life markers in multiple sclerosis: DISCOMS secondary analysis.
Therapeutic advances in neurological disorders·2026